Activity of type IV collagenases in benign and malignant breast disease
- PMID: 8494711
- PMCID: PMC1968428
- DOI: 10.1038/bjc.1993.207
Activity of type IV collagenases in benign and malignant breast disease
Abstract
Using zymography and computer assisted image analysis, we have measured the levels of type IV collagenases in biopsies from normal breast, and benign and malignant breast disease. The 92 kDa form was present in three of 11 cases of normal/benign disease, three of nine grade I tumours, four of 12 grade II tumours, but 11 of 11 grade III tumours. Mean levels were higher in grade III tumours (P < 0.0001). When the levels of 72 kDa collagenase and its active 62 kDa form were considered together, there was no difference between the benign and malignant cases (P = 0.55), but the amount of active enzyme, considered as a proportion of the 62 + 72 kDa forms, was significantly higher in malignant disease (P = 0.003). There was also a trend towards a higher proportion of active enzyme with increasing tumour grade (P < 0.0001). In situ hybridisation and immunohistochemistry studies showed that that mRNA and protein for the 92 kDa enzyme was primarily found in the tumour stroma. mRNA for the 72 kDa enzyme was also found in stromal areas. This study demonstrates a clear relationship between production of Type IV collagenases and malignant breast disease. Inhibitors of these enzymes may be of value in preventing metastatic disease.
Similar articles
-
Synthesis and degradation of basement membranes in benign and malignant salivary gland tumours. A study by in situ hybridization.J Pathol. 1993 Jul;170(3):291-6. doi: 10.1002/path.1711700312. J Pathol. 1993. PMID: 8133403
-
Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.Oncol Res. 1993;5(1):19-28. Oncol Res. 1993. PMID: 8369572
-
Stimulation of type IV collagenase expression by linoleic acid in a metastatic human breast cancer cell line.Cancer Lett. 1994 Jan 15;76(1):71-7. doi: 10.1016/0304-3835(94)90136-8. Cancer Lett. 1994. PMID: 8124668
-
Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.Am J Pathol. 1993 Feb;142(2):359-65. Am J Pathol. 1993. PMID: 8434636 Free PMC article.
-
Type IV collagenases in invasive tumors.Breast Cancer Res Treat. 1993;24(3):209-18. doi: 10.1007/BF01833261. Breast Cancer Res Treat. 1993. PMID: 8435476 Review.
Cited by
-
Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.J Mol Histol. 2004 Jun;35(5):443-55. doi: 10.1023/b:hijo.0000045943.26251.24. J Mol Histol. 2004. PMID: 15571322
-
Evaluation of microRNA-9 and -192 expression levels as biomarkers in patients suffering from breast cancer.Biomed Rep. 2020 Jan;12(1):30-34. doi: 10.3892/br.2019.1257. Epub 2019 Nov 21. Biomed Rep. 2020. PMID: 31839947 Free PMC article.
-
The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues.Int J Exp Pathol. 2003 Apr;84(2):69-74. doi: 10.1046/j.1365-2613.2003.00336.x. Int J Exp Pathol. 2003. PMID: 12801280 Free PMC article.
-
Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.Virchows Arch. 2004 Jun;444(6):518-26. doi: 10.1007/s00428-004-1016-2. Epub 2004 Apr 16. Virchows Arch. 2004. PMID: 15088144
-
Cytokines in tumour growth, migration and metastasis.World J Urol. 1996;14(3):157-65. doi: 10.1007/BF00186895. World J Urol. 1996. PMID: 8806194 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical